2021
DOI: 10.1155/2021/9923440
|View full text |Cite
|
Sign up to set email alerts
|

Endovascular Treatment of Right Heart Masses Utilizing the AngioVac System: A 6-Year Single-Center Observational Study

Abstract: Objective. To describe our institution’s experience with the AngioVac system. Background. Intracardiac and intravascular masses previously required surgical excision, but now, there are a number of minimally invasive options. With the advent of vacuum aspiration, more specifically the AngioVac System (AngioDynamics, NY, USA), there exists a system with both low mortality and minor complications. However, the number of retrospective studies remains limited. Outcome data for high-risk patients are also limited. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 17 publications
1
5
0
Order By: Relevance
“…For example, in 1 study looking at the Angiovac thrombectomy platform, a similarly high success rate of 94.1% was demonstrated. 19 Moreover, we also confirmed a low rate of major complications attributed to these therapies, including intracranial hemorrhage, the most feared postprocedural complication. These findings suggest the feasibility of these advanced modalities in select patients with RHT.…”
Section: Discussionsupporting
confidence: 74%
“…For example, in 1 study looking at the Angiovac thrombectomy platform, a similarly high success rate of 94.1% was demonstrated. 19 Moreover, we also confirmed a low rate of major complications attributed to these therapies, including intracranial hemorrhage, the most feared postprocedural complication. These findings suggest the feasibility of these advanced modalities in select patients with RHT.…”
Section: Discussionsupporting
confidence: 74%
“… 2 , 3 Other interventional strategies, such as catheter-based aspiration technologies or the use of retrieval devices, have also been described to offer minimally invasive alternatives to surgical thrombectomy with low procedure-associated risks. 2 , 3 , 4 , 5 …”
Section: Discussionmentioning
confidence: 99%
“…Periprocedural embolic complications were previously reported in 1–5.9 % of patients undergoing percutaneous aspiration using AngioVac [ 3 , 5 ]. In the current report there were no obvious peri-procedural embolic complications.…”
Section: Discussionmentioning
confidence: 99%